Congressional Trader
Live

REGN congressional trades

15 matched disclosures

Track congressional trades for REGN
Tracked disclosures
15
Lawmakers
9
Buy / sell
6 / 9
Avg post-trade move
N/A
Latest filing 2026-03-12

REGN congressional trades snapshot

This page summarizes public STOCK Act disclosures involving REGN. It is useful for seeing which lawmakers reported REGN transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Mar 12, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the REGN congressional trade page shows

Congressional Trader tracks 15 public STOCK Act disclosures for REGNacross 9 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent REGN filing shown here was filed on Mar 12, 2026 by Julia Letlow as a purchase. Related lawmakers include Robert P. Bresnahan, Byron Donalds, Greg Landsman, Jonathan L. Jackson, Julie Johnson.

Top lawmakers for REGN

Robert P. Bresnahan3 filingsByron Donalds2 filingsGreg Landsman2 filingsJonathan L. Jackson2 filingsJulie Johnson2 filingsGilbert Ray Cisneros1 filingsJefferson Shreve1 filingsJosh Gottheimer1 filingsJulia Letlow1 filings

Related paths

Alerts for REGNCongressional stock trading trackerLatest disclosuresHealthcare

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
Julia LetlowR-LAHouse
No committee data
Filed Mar 12, 2026
Delay 28 days
View filing
REGNNotable
Regeneron Pharmaceuticals, Inc. -
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Gilbert Ray CisnerosD-CAHouse
No committee data
Filed Dec 15, 2025
Delay 27 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Robert P. BresnahanR-PAHouse
No committee data
Filed Jun 9, 2025
Delay 25 days
View filing
REGNNotable
Regeneron Pharmaceuticals, Inc. -
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Byron DonaldsR-FLHouse
No committee data
Filed May 24, 2025
Delay 44 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. -
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Byron DonaldsR-FLHouse
No committee data
Filed May 24, 2025
Delay 44 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Julie JohnsonD-TXHouse
No committee data
Filed May 14, 2025
Delay 43 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. -
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Robert P. BresnahanR-PAHouse
No committee data
Filed May 8, 2025
Delay 30 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Jefferson ShreveR-INHouse
No committee data
Filed May 8, 2025
Delay 31 days
View filing
REGNNotable
Regeneron Pharmaceuticals, Inc. - Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Robert P. BresnahanR-PAHouse
No committee data
Filed Mar 27, 2025
Delay 30 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. -
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Julie JohnsonD-TXHouse
No committee data
Filed Feb 12, 2025
Delay 28 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Josh GottheimerD-NJHouse
No committee data
Filed Feb 10, 2025
Delay 17 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Jonathan L. JacksonD-ILHouse
No committee data
Filed Dec 12, 2024
Delay 29 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Greg LandsmanD-OHHouse
No committee data
Filed Nov 14, 2024
Delay 30 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Greg LandsmanD-OHHouse
No committee data
Filed Aug 14, 2024
Delay 369 days
View filing
REGNNotable
Regeneron Pharmaceuticals, Inc. -
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Jonathan L. JacksonD-ILHouse
No committee data
Filed Feb 15, 2024
Delay 29 days
View filing
REGN
Regeneron Pharmaceuticals, Inc. -
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded REGN?

Recent REGN disclosures include Robert P. Bresnahan, Byron Donalds, Greg Landsman, Jonathan L. Jackson, Julie Johnson.

What is the buy/sell mix for REGN?

The visible sample currently shows 6 purchases and 9 sales or partial sales.

Should I trade based on REGN disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.